Evidence map›Paper›PMID 29788348›Full record

ArticleThe Journal of infectious diseases2018

Participant Retention in a Randomized Clinical Trial in an Outbreak Setting: Lessons From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).

Rosalind J Carter, Reynold G B Senesi, Peter Dawson, Ibrahim Gassama, S A S Kargbo, Carey R Petrie, Mohamed Hashim Rogers, Mohamed Samai, Elizabeth T Luman

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02378753 ([rVSVΔG-ZEBOV] Ebola Prevention Vaccine Evaluation in Sierra Leone), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02378753 phase2 / phase3completednot on this map

[rVSVΔG-ZEBOV] Ebola Prevention Vaccine Evaluation in Sierra Leone

TypeinterventionalSponsorCenters for Disease Control and PreventionRan2015 to 2016Enrolled8,651ConditionsHemorrhagic Fever, EbolaArmsrVSVΔG-ZEBOV
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Logistics of Implementing a Large-scale Typhoid Vaccine Trial in Kathmandu, Nepal.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Rosalind J CarterCenters for Disease Control and Prevention, Atlanta, Georgia.
Reynold G B SenesiCollege of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.
Peter DawsonThe Emmes Corporation, Washington, DC.
Ibrahim GassamaCollege of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.
S A S KargboMinistry of Health and Sanitation, Freetown, Sierra Leone.
Carey R PetrieThe Emmes Corporation, Washington, DC.
Mohamed Hashim RogersCollege of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.
Mohamed SamaiCollege of Medicine and Allied Health Sciences, University of Sierra Leone, Freetown, Sierra Leone.
Elizabeth T LumanCenters for Disease Control and Prevention, Atlanta, Georgia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clinical Trials Registration: ClinicalTrials.gov [NCT02378753] and Pan African Clinical Trials Registry [PACTR201502001037220].

Indexed as

Disease OutbreaksAdolescentAdultAgedAged, 80 and overClinical Trials, Phase II as TopicClinical Trials, Phase III as TopicDrug-Related Side Effects and Adverse ReactionsEbola VaccinesFemaleFollow-Up StudiesHemorrhagic Fever, EbolaHumansMaleMiddle AgedRandomized Controlled Trials as TopicEbola Vaccines

Identifiers

PMID29788348
PMCPMC5961184

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.